We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$405M
AUM Growth
-$11.8M
Cap. Flow
-$9.04M
Cap. Flow %
-2.23%
Top 10 Hldgs %
15.35%
Holding
294
New
21
Increased
45
Reduced
123
Closed
29

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$1.32M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$501K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$425K
4
ULTA icon
Ulta Beauty
ULTA
+$404K
5
ZEN
ZENDESK INC
ZEN
+$402K

Top Sells

Rank Stock Value
1
LLL
L3 Technologies, Inc.
LLL
+$1.37M
2
REKR icon
Rekor Systems
REKR
+$632K
3
SRPT icon
Sarepta Therapeutics
SRPT
+$329K
4
DXCM icon
DexCom
DXCM
+$326K
5
XYZ
Block Inc
XYZ
+$326K

Sector Composition

Rank Sector Weight
1 Technology 19.2%
2 Industrials 16.97%
3 Healthcare 11.23%
4 Consumer Discretionary 6.77%
5 Financials 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGN icon
201
Align Technology
ALGN
$12.5B
$222K 0.05%
+1,226
New +$255K
TJX icon
202
TJX Companies
TJX
$172B
$221K 0.05%
3,957
– –
MFC icon
203
Manulife Financial
MFC
$70.6B
$212K 0.05%
11,542
– –
MDGL icon
204
Madrigal Pharmaceuticals
MDGL
$12.4B
$211K 0.05%
2,447
– –
LOGC
205
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$211K 0.05%
19,530
– –
RSP icon
206
Invesco S&P 500 Equal Weight ETF
RSP
$95.5B
$210K 0.05%
+1,945
New +$209K
XLNX
207
DELISTED
Xilinx Inc
XLNX
$209K 0.05%
2,184
– –
XLK icon
208
State Street Technology Select Sector SPDR ETF
XLK
$114B
$202K 0.05%
5,008
– –
CTRA
209
DELISTED
Coterra Energy
CTRA
$194K 0.05%
+11,061
New +$212K
ALNY icon
210
Alnylam Pharmaceuticals
ALNY
$36.4B
– –
-3,023
Closed -$219K
BL icon
211
BlackLine
BL
$1.77B
– –
-5,186
Closed -$278K
BLUE
212
DELISTED
bluebird bio
BLUE
– –
-148
Closed -$243K
DXCM icon
213
DexCom
DXCM
$29.2B
– –
-8,692
Closed -$326K
ESTC icon
214
Elastic
ESTC
$6.52B
– –
-3,487
Closed -$260K
FOLD
215
DELISTED
Amicus Therapeutics
FOLD
– –
-21,082
Closed -$263K
INGR icon
216
Ingredion
INGR
$6.46B
– –
-2,754
Closed -$227K
MKSI icon
217
MKS Inc
MKSI
$21.9B
– –
-2,862
Closed -$223K
MORN icon
218
Morningstar
MORN
$6.53B
– –
-1,872
Closed -$271K
RARE icon
219
Ultragenyx Pharmaceutical
RARE
$2.81B
– –
-4,080
Closed -$259K
REGN icon
220
Regeneron Pharmaceuticals
REGN
$70.5B
– –
-757
Closed -$237K
ROK icon
221
Rockwell Automation
ROK
$51B
– –
-1,428
Closed -$234K
SGMO
222
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-27,059
Closed -$291K
SRPT icon
223
Sarepta Therapeutics
SRPT
$1.78B
– –
-2,168
Closed -$329K
SXT icon
224
Sensient Technologies
SXT
$4.67B
– –
-2,667
Closed -$196K
VKTX icon
225
Viking Therapeutics
VKTX
$4.22B
– –
-30,815
Closed -$256K
6 7 8
9
10

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2019 Portfolio in Review

As of Q3 2019, Stanley-Laman Group held 294 positions worth $405M, down 2.8% from $417M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Stanley-Laman Group's Q3 2019 filing shows 21 new, 45 increased, 123 reduced and 29 closed positions. Its largest new stake was ZENDESK INC: 4,885 shares worth $356K. The largest sale was L3 Technologies, Inc., an estimated $1.37M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q3 2019 buy was ZENDESK INC: 4,885 shares worth $356K.
  • Stanley-Laman Group added most to L3Harris in Q3 2019, an estimated $1.32M increase.
  • Stanley-Laman Group's biggest Q3 2019 reduction was Rekor Systems, cutting an estimated $632K.
  • Stanley-Laman Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $1.37M.
  • Stanley-Laman Group's ten largest holdings make up 15% of its $405M portfolio in Q3 2019.
  • Stanley-Laman Group opened 21 new positions and closed 29 in Q3 2019.
  • Stanley-Laman Group's portfolio value fell 2.8% quarter-over-quarter to $405M.

Based on Stanley-Laman Group's 13F filing for Q3 2019, filed 8 Nov 2019.